| Cixutumumab studied in …STUDIED_INderived43 of 43show fewer |
|---|
| → studied in | NCT01142388Phase 2 · active not recruiting Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer · 43 trials list this drug (1 active) | — | — | Malignant Esophageal Neoplasm,Esophageal Carcinoma,Esophageal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887159Phase 2 · completed A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage · 43 trials list this drug (1 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617708Phase 1/Phase 2 · completed S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery · 43 trials list this drug (1 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684983Phase 2 · completed Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer · 43 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00957853Phase 2 · completed Preoperative Treatment With Cetuximab and/or IMC-A12 · 43 trials list this drug (1 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413191Phase 2 · completed Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye · 43 trials list this drug (1 active) | — | — | Uveal Melanoma,Iris Melanoma,Medium/Large Size Posterior Uveal Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00781911Phase 2 · completed A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer · 43 trials list this drug (1 active) | — | — | Carcinoma,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01232452Phase 2 · completed A Study in Non-Small Cell Lung Cancer · 43 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026623Phase 1/Phase 2 · completed Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer · 43 trials list this drug (1 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01263782Phase 2 · completed BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer · 43 trials list this drug (1 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01007032Phase 1 · completed A Study of IMC-A12 in Advanced Solid Tumors · 43 trials list this drug (1 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00785538Phase 1 · completed A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available · 43 trials list this drug (1 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · 43 trials list this drug (1 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Osteosarcoma,Childhood Angiosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520481Phase 2 · completed Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer · 43 trials list this drug (1 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668148Phase 2 · completed A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma · 43 trials list this drug (1 active) | — | — | Primitive Neuroectodermal Tumor,Leiomyosarcoma,Rhabdomyosarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00845039Phase 2 · terminated A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab · 43 trials list this drug (1 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00699491Phase 1/Phase 2 · completed Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer · 43 trials list this drug (1 active) | — | — | Breast Carcinoma,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503685Phase 2 · completed Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy · 43 trials list this drug (1 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00728949Phase 2 · completed A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer · 43 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00955305Phase 2 · terminated Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · 43 trials list this drug (1 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00906373Phase 2 · completed A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver · 43 trials list this drug (1 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00870870Phase 2 · completed A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before · 43 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617734Phase 2 · completed Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck · 43 trials list this drug (1 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160458Phase 2 · completed Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy · 43 trials list this drug (1 active) | — | — | Peritoneal Mesothelial Neoplasm,Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120236Phase 2 · completed Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer · 43 trials list this drug (1 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01055314Phase 2 · completed Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma · 43 trials list this drug (1 active) | — | — | Adult Soft Tissue Sarcoma,Childhood Soft Tissue Sarcoma,Adult Rhabdomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01182883Phase 1 · withdrawn A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors · 43 trials list this drug (1 active) | — | — | Glioma,Brain Stem Neoplasm,Pineal Region Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769795Phase 2 · completed Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer · 43 trials list this drug (1 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · 43 trials list this drug (1 active) | — | — | Paraganglioma,Digestive System Neuroendocrine Tumor G1,Gastrin-Producing Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · 43 trials list this drug (1 active) | — | — | Adult Fibrosarcoma,Adult Liposarcoma,Adult Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01008566Phase 1 · completed Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer · 43 trials list this drug (1 active) | — | — | Adult Liver Carcinoma,Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061749Phase 1 · completed Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies · 43 trials list this drug (1 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678769Phase 1 · completed Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer · 43 trials list this drug (1 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01016015Phase 2 · completed Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma · 43 trials list this drug (1 active) | — | — | Osteosarcoma,Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831844Phase 2 · completed Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors · 43 trials list this drug (1 active) | — | — | Primitive Neuroectodermal Tumor,Childhood Hepatoblastoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00683475Phase 2 · completed A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer · 43 trials list this drug (1 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00986674Phase 2 · completed Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer · 43 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00609141Phase 1 · completed IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor · 43 trials list this drug (1 active) | — | — | Childhood Solid Neoplasm,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00639509Phase 2 · completed IMC-A12 in Treating Patients With Advanced Liver Cancer · 43 trials list this drug (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778167Phase 1/Phase 2 · completed Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 43 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778817Phase 2 · terminated IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery · 43 trials list this drug (1 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880282Phase 1 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment · 43 trials list this drug (1 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00785941Phase 1 · completed A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available · 43 trials list this drug (1 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |